Insider · CIK 0001240122

GREY MICHAEL G

Reports to the SEC for 9 companies · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001240122

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-07	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.4K sh	—	—	22,350
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,772 sh	—	—	3,772
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	1,980
2026-06-04	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2026-05-21	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+1,700 sh	—	—	1,700
2025-12-19	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	181,176
2025-12-19	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.94	+$147K	50,000
2025-12-19	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−50K sh	$78.00	−$3.9M	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+387 sh	—	—	387
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (right to buy)A Award	Director, Executive Chairman	AAward	+133 sh	—	—	133
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−387 sh	—	—	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−1,499 sh	—	—	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−1,255 sh	—	—	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−666 sh	—	—	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+400 sh	—	—	400
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−400 sh	—	—	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+666 sh	—	—	666
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (right to buy)D Disposition to Issuer	Director, Executive Chairman	DDisposition to Issuer	−133 sh	—	—	0
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+1,499 sh	—	—	1,499
2025-12-11	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+1,255 sh	—	—	1,255
2025-12-01	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	231,176
2025-12-01	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−50K sh	$74.00	−$3.7M	0
2025-12-01	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.94	+$147K	50,000
2025-11-21	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	281,176
2025-11-21	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−50K sh	$70.00	−$3.5M	0
2025-11-21	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.94	+$147K	50,000
2025-07-22	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+30K sh	—	—	30,000
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,268 sh	—	—	6,268
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+3,977 sh	—	—	3,977
2025-05-28	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,650 sh	—	—	7,650
2024-10-04	OKUROnKure Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.3K sh	—	—	15,300
2024-09-27	MIRMMirum Pharmaceuticals, Inc.G Gift	Director	GGift	−103K sh	—	—	186,410
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+8,779 sh	—	—	8,779
2024-06-05	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+5,703 sh	—	—	5,703
2024-05-22	SPRBSPRUCE BIOSCIENCES, INC. · Stock Option (Right to Buy)A Award	Director, Executive Chairman	AAward	+30K sh	—	—	30,000
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,016 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−31.2K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.1K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,548 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	$116.50	−$1.17M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−48K sh	$116.50	−$5.6M	0
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	Director	DDisposition to Issuer	−39.4K sh	$116.50	−$4.59M	0
2023-09-28	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$15.96	+$319K	39,361
2023-09-28	Horizon Therapeutics Public Ltd CoStock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2023-09-14	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−14.2K sh	$32.00	−$455K	0
2023-09-14	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.2K sh	$2.94	+$41.7K	14,216
2023-09-14	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−14.2K sh	—	—	331,176
2023-09-13	MIRMMirum Pharmaceuticals, Inc.S Sale	Director	SSale	−392 sh	$32.00	−$12.5K	0
2023-09-13	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+392 sh	$2.94	+$1,150.912	392

Recent filings

Accepted (ET)
Aug 114
GREY MICHAEL G0001240122-26-000006
SEC(opens sec.gov)
Jun 174
GREY MICHAEL G0001240122-26-000005
SEC(opens sec.gov)
Jun 84
GREY MICHAEL G0001240122-26-000003
SEC(opens sec.gov)
May 264
GREY MICHAEL G0001240122-26-000002
SEC(opens sec.gov)
Dec 234
GREY MICHAEL G0001240122-25-000011
SEC(opens sec.gov)
Dec 154
GREY MICHAEL G0001240122-25-000009
SEC(opens sec.gov)

Companies

Address

C/O ONKURE THERAPEUTICS, INC. 6707 WINCHESTERR CIRCLE, SUITE 400

BOULDER, CO, 80301